Keyword: Donald Trump

Two Democratic senators are looking into whether Rudy Giuliani secured leniency for Purdue Pharma through conflicts of interest.

The Senate voted in favor of drug pricing in DTC ads, while HHS works on a transparency proposal for Medicare and Medicaid.

Trump's request comes as the DOJ and DEA propose to cut production quotas for the six most frequently misused opioids by 10% next year.

Apotex has secured the FDA's first approval as part of a new program designed to boost competition in certain drug classes.

Trump reportedly told reporters before the dinner that he would make an announcement next week that would bring down drug prices “really substantially.”

What would a world with no drug rebates look like? Pfizer’s Ian Read is already imagining it.

Think President Trump's bid to slap price tags on drug ads is all talk? Think again. In recent days, the idea has gained steam—and bipartisan backing.

Celgene is extracting volume-driven sales growth as the entire industry has come under scrutiny for its pricing.

PhRMA spent $15.5 million lobbying in the first half of the year, an 11.5% increase compared with the same period last year.

A closer look at the Merck's new pricing plan reveals it really isn’t changing all that much, analysts say.